ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106995 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106995; 2) Community: the network communities that were significantly associated with the response to NSC 106995; 3) Molecule: the relationships between components within communities and NSC 106995; 4) MDR: the compounds that were significantly associated with the NSC 106995.

NSC Compound Enrichment Correlation
NSC 352122 Trimetrexate glucuronate 0.013148061243004 0.50220969
NSC 382050 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)- 6-ethyl-, monoethanesulfonate 0.013148061243004 0.31079117
NSC 693563 Null 0.013148061243004 0.33540756
NSC 704556 Null 0.013148061243004 0.20001414
NSC 736988 6-(3-Aminopropyl)-5,6-dihydro-9-methoxy-5,11-dioxo-11H-inden o[1,2-c]isoquinoline Hydrochloride 0.013148061243004 0.3532083
NSC 737671 6-(3-Aminopropyl)-5,6-dihbydro-3-nitro-5,11-dioxo-9-phenyl-1 1H[1,2-c]isoquinoline Hydrochloride 0.013148061243004 0.27769741
NSC 107124 Camptothecin Derivative 0.0152653588725063 0.34672764
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0152653588725063 0.55488962
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0152653588725063 0.26756516
NSC 134725 K-33 0.0152653588725063 0.20424093
Total:57  Current:17    [First] [Prev] [Next] [Last]